Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Active Motif Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner in 1 distinct art unit. The company's current patent activity is focused on a single point of examination, which suggests a targeted approach to protecting its biotechnology innovations. This concentration allows for a very specific prosecution strategy but also means the company's immediate success is tied to a single examiner's perspective. The use of 1 art unit indicates the technology is classified within a narrow technical field.
JOHANNSEN, DIANA B is the busiest examiner for the portfolio, managing 1 busiest examiner pending action. This examiner is responsible for the company's entire pending workload. The concentration in 1 art unit implies that the technology is being evaluated against a specific set of biotechnology standards. For Active Motif Inc., the resolution of this 1 pending action is the critical path for its current intellectual property goals. The examiner's interpretation of the prior art within this 1 art unit will be the deciding factor for the application. Practitioners should monitor the examiner's specific requirements in the Biotechnology & Pharmaceuticals area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHANNSEN, DIANA B | 1 | 53.3% | +42.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17616147 | METHODS AND KITS FOR THE ENRICHMENT AND DETECTION OF DNA AND RNA MODIFICATIONS AND FUNCTIONAL MOTIFS | JOHANNSEN, DIANA B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17616147 | METHODS AND KITS FOR THE ENRICHMENT AND DETECTION OF DNA AND RNA MODIFICATIONS AND FUNCTIONAL MOTIFS | JOHANNSEN, DIANA B | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17616147 | METHODS AND KITS FOR THE ENRICHMENT AND DETECTION OF DNA AND RNA MODIFICATIONS AND FUNCTIONAL MOTIFS | JOHANNSEN, DIANA B | 1682 | §103§112 | Final Rejection | — | Pending | Dec 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialActive Motif Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Diana B Johannsen has the most, with 1 of Active Motif Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.